Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 10Terminated 3Unknown 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Breast Neoplasms 1296Carcinoma, Non-Small-Cell Lung 793Neoplasms 787Colorectal Neoplasms 760Stomach Neoplasms 587Carcinoma, Hepatocellular 581Prostatic Neoplasms 514Lung Neoplasms 466Pancreatic Neoplasms 421Rectal Neoplasms 336Recurrence 314Neoplasm Metastasis 308Leukemia, Myeloid, Acute 293Colonic Neoplasms 283Multiple Myeloma 280Lymphoma 276Esophageal Neoplasms 273Uterine Cervical Neoplasms 272Ovarian Neoplasms 263Melanoma 246Head and Neck Neoplasms 245Precursor Cell Lymphoblastic Leukemia-Lymphoma 210Brain Neoplasms 195Lymphoma, Large B-Cell, Diffuse 187Nasopharyngeal Carcinoma 182Leukemia 173Lymphoma, Non-Hodgkin 171Liver Neoplasms 165Glioblastoma 160Polycystic Ovary Syndrome 157

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Dermatitis × Clear all
NCT02580279 2019-04-05

Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy

Shandong Cancer Hospital and Institute

Phase 2 Unknown
68 enrolled
Breast

Breast Neoplasms, Dermatitis

NCT02346318 2017-07-21

The Randomized Controlled Clinical Trial of Kushen Injection

Beijing Zheng Ju Medical Technology Co., Ltd.

Phase 4 Unknown
240 enrolled
Thoracic

Dermatitis, Eczema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡